Sakboonyarat, Boonsub
Poovieng, Jaturon
Sangkool, Tanatip
Lertsakulbunlue, Sethapong
Jongcherdchootrakul, Kanlaya
Srisawat, Phutsapong
Mungthin, Mathirut
Rangsin, Ram
Article History
Received: 27 March 2023
Accepted: 11 July 2023
First Online: 18 July 2023
Declarations
:
: This study was reviewed and approved by the Institutional Review Board, Royal Thai Army Medical Department, according to international guidelines such as the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use–Good Clinical Practice (ICH–GCP) (approval number S056h/65). As a result of using secondary data, a waiver of documentation of informed consent was utilized. The Institutional Review Board, Royal Thai Army Medical Department, approved an informed consent waiver.
: The authors declare that they have no competing interests.
: Consent for publication is not applicable.